The future of pharmacology

Quantitative spectroscopy of single molecule interaction times.

Optics letters·2021

A functional genetic variation of SLC6A2 repressor hsa-miR-579-3p upregulates sympathetic noradrenergic processes of fear and anxiety.

Translational psychiatry·2018

All-optical microscope autofocus based on an electrically tunable lens and a totally internally reflected IR laser.

Optics express·2018

Increased fear learning, spatial learning as well as neophobia in Rgs2-/- mice.

Genes, brain, and behavior·2017

Antibodies to cardiac receptors.

Herz·2012

G-protein-coupled receptor kinases and the heart.

Trends in cardiovascular medicine·2011

Reprogramming pain signaling through photopharmacology.

Trends in pharmacological sciences·2026

Lysosome-targeted protein degradation platforms for spatiotemporally controlled degradation.

Trends in pharmacological sciences·2026

Sex-sensitive serotonergic signaling in psychedelic pharmacology.

Trends in pharmacological sciences·2026

Amyloidogenic amylin signaling links diabetes to dementia pathogenesis.

Trends in pharmacological sciences·2026

STAT3 signaling inhibitors for cancer treatment.

Trends in pharmacological sciences·2026

STING-mediated cancer immunotherapy: emerging modalities and beyond.

Trends in pharmacological sciences·2026

Utilization patterns of second-generation androgen receptor pathway inhibitors as first-line therapy for prostate cancer in the United States.

Prostate cancer and prostatic diseases·2026

Progress on novel compounds for the treatment of bone metabolism-related disorders: focus on osteoporosis and beyond.

Frontiers in chemistry·2026

Clinical Approach to Impulse Control-Related Behavioral Disorders in Parkinson's Disease: A Scoping Review.

Movement disorders clinical practice·2026

Prescribing and monitoring of riluzole in amyotrophic lateral sclerosis: a retrospective cohort study from Health New Zealand - Te Whatu Ora Waitaha Canterbury.

The New Zealand medical journal·2026

Researchers struggle to improve nonopioid pain drugs.

Science (New York, N.Y.)·2026

Patterns and Trends in Vasoactive Medication Use in Patients With Pulmonary Arterial Hypertension Presenting With Shock.

Pulmonary circulation·2026

Related Experiment Videos

The future of pharmacology

Related Concept Videos

Quantitative spectroscopy of single molecule interaction times.

A functional genetic variation of SLC6A2 repressor hsa-miR-579-3p upregulates sympathetic noradrenergic processes of fear and anxiety.

All-optical microscope autofocus based on an electrically tunable lens and a totally internally reflected IR laser.

Increased fear learning, spatial learning as well as neophobia in Rgs2-/- mice.

Antibodies to cardiac receptors.

G-protein-coupled receptor kinases and the heart.

Reprogramming pain signaling through photopharmacology.

Lysosome-targeted protein degradation platforms for spatiotemporally controlled degradation.

Sex-sensitive serotonergic signaling in psychedelic pharmacology.

Amyloidogenic amylin signaling links diabetes to dementia pathogenesis.

STAT3 signaling inhibitors for cancer treatment.

STING-mediated cancer immunotherapy: emerging modalities and beyond.

Utilization patterns of second-generation androgen receptor pathway inhibitors as first-line therapy for prostate cancer in the United States.

Progress on novel compounds for the treatment of bone metabolism-related disorders: focus on osteoporosis and beyond.

Clinical Approach to Impulse Control-Related Behavioral Disorders in Parkinson's Disease: A Scoping Review.

Prescribing and monitoring of riluzole in amyotrophic lateral sclerosis: a retrospective cohort study from Health New Zealand - Te Whatu Ora Waitaha Canterbury.

Researchers struggle to improve nonopioid pain drugs.

Patterns and Trends in Vasoactive Medication Use in Patients With Pulmonary Arterial Hypertension Presenting With Shock.

Related Experiment Videos

The future of pharmacology

Related Concept Videos

Related Articles